Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Ekins

Showing results (71-80 of 374) with videos related to

Pageof 38
Sort By:
Current Opinion in Chemical Biology|July 18, 2021
Recent advances in drug repurposing using machine learningFabio Urbina, Ana C Puhl, Sean Ekins
Trends in Pharmacological Sciences|February 4, 2009
The importance of discerning shape in molecular pharmacologySandhya Kortagere, Matthew D Krasowski, Sean Ekins
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 16, 2014
Quantitative NTCP pharmacophore and lack of association between DILI and NTCP InhibitionZhongqi Dong, Sean Ekins, James E Polli
F1000Research|September 21, 2017
The new alchemy: Online networking, data sharing and research activity distribution tools for scientistsAntony J Williams, Lou Peck, Sean Ekins
Drug Discovery Today|September 25, 2016
Raising awareness of the importance of funding for tuberculosis small-molecule researchGiovanna Riccardi, Iain G Old, Sean Ekins
International Journal of Pharmaceutics|December 3, 2014
A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptideZhongqi Dong, Sean Ekins, James E Polli
Drug Discovery Today|November 20, 2012
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidatesChristopher Southan, Antony J Williams, Sean Ekins
Pharmaceutical Research|January 14, 2003
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbetaSean Ekins, Leonid Mirny, Erin G Schuetz
Pharmaceutical Research|June 13, 2020
Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na<sub>v</sub>1.8 Inhibitor In Vivo for Pitt Hopkins SyndromeSean Ekins, Ana C Puhl, Audrey Davidow
Pharmaceutical Research|May 14, 2009
Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testingLei Diao, Sean Ekins, James E Polli
Pageof 38

Showing results (71-80 of 374) with videos related to

Sort By:
Pageof 38
Current Opinion in Chemical Biology|July 18, 2021
Recent advances in drug repurposing using machine learningFabio Urbina, Ana C Puhl, Sean Ekins
Trends in Pharmacological Sciences|February 4, 2009
The importance of discerning shape in molecular pharmacologySandhya Kortagere, Matthew D Krasowski, Sean Ekins
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 16, 2014
Quantitative NTCP pharmacophore and lack of association between DILI and NTCP InhibitionZhongqi Dong, Sean Ekins, James E Polli
F1000Research|September 21, 2017
The new alchemy: Online networking, data sharing and research activity distribution tools for scientistsAntony J Williams, Lou Peck, Sean Ekins
Drug Discovery Today|September 25, 2016
Raising awareness of the importance of funding for tuberculosis small-molecule researchGiovanna Riccardi, Iain G Old, Sean Ekins
International Journal of Pharmaceutics|December 3, 2014
A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptideZhongqi Dong, Sean Ekins, James E Polli
Drug Discovery Today|November 20, 2012
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidatesChristopher Southan, Antony J Williams, Sean Ekins
Pharmaceutical Research|January 14, 2003
A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbetaSean Ekins, Leonid Mirny, Erin G Schuetz
Pharmaceutical Research|June 13, 2020
Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na<sub>v</sub>1.8 Inhibitor In Vivo for Pitt Hopkins SyndromeSean Ekins, Ana C Puhl, Audrey Davidow
Pharmaceutical Research|May 14, 2009
Novel inhibitors of human organic cation/carnitine transporter (hOCTN2) via computational modeling and in vitro testingLei Diao, Sean Ekins, James E Polli
Pageof 38